Definitive Contract 36C26122C0017

Award Date 3/1/22
Potential Completion Date 2/28/27
Potential Value $960K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Brisbane, CA 94005, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Caredx, Inc., a for-profit organization headquartered in Brisbane, California, is for the provision of AlloMap gene testing services. The contract, valued at $158,760.00, was awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) and has an ultimate completion date of July 31, 2027. Caredx, a leading provider of specialized transplant diagnostic solutions, will deliver its AlloMap gene testing services...
This is a $245,479.74 firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract is for the provision of testing kits for post-transplant patients and does not have a set-aside designation. Caredx, headquartered in Brisbane, California, will provide specialized...
The federal contract award is for laboratory services provided by Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract, valued at $241,463.75, was awarded by the U.S. Department of Veterans Affairs (VA) to Caredx for the delivery of advanced genetic and molecular testing solutions focused on organ transplant diagnostics. The contract, which has a completion date of January 14, 2026, is a Firm Fixed Price Delivery Order, with no set-aside...
This is a $193,171.00 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract is for laboratory reference testing services, specifically Caredx's specialized diagnostic solutions for organ transplant patients, including its AlloMap and AlloSure genetic and molecular testing products. The contract has an ultimate completion date of January 14,...
This federal contract award, valued at $392,628.24, was issued by the Veterans Integrated Service Network 9 (VISN 9) of the Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization that specializes in providing advanced medical testing products and services to support organ transplant programs. The contract covers the provision of Caredx's AlloMap and AlloSure genetic blood testing services for transplant patients. Caredx has a strong history of securing VA contracts for...
The Department of Veterans Affairs (VA) awarded a $247,578.50 firm fixed-price purchase order contract to Caredx, Inc., a for-profit healthcare organization, for the provision of AlloSure kidney donor-derived cell-free DNA testing kits and services. The contract has an ultimate completion date of October 18, 2027 and was issued through the VA's Veterans Integrated Service Network (VISN) 6. The original solicitation was an unrestricted request for AlloSure kidney testing kits to support the...
This federal contract award to Caredx, Inc., a for-profit medical testing company, is for the provision of specialized genetic testing services to support organ transplant programs for the U.S. Department of Veterans Affairs (VA). The contract, valued at $529,760.00, is a delivery order awarded under a larger Indefinite Delivery Vehicle (IDV) contract with a $1,963,141.20 ceiling for genetic blood testing services. Caredx will supply the VA with its AlloSure kidney and heart tests, AlloMap heart...
This is a definitive contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $244,800.00, is for laboratory tests and specialty transplant services. The contract is not set aside and was awarded under the VA's Veterans Integrated Service Network 9 (VISN 9) to Caredx, which has been awarded multiple indefinite...
This federal contract award to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California, is for the provision of AlloSure kidney testing kits. The award, valued at $676,098.50, is a delivery order contract with a firm fixed price pricing type. The contracting agency is the Department of Veterans Affairs (VA) and the specific VA entity is Veterans Integrated Service Network 12 (VISN 12). The contract is not designated as a set-aside. Caredx has been awarded...
This is a federal contract awarded by the Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $412,217.17, is for HEART TRANSPLANT REJECTION TESTING services. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and the ultimate completion date is February 28, 2022. The contract was awarded on September 1, 2016 and...

The Department of Veterans Affairs (VA) has awarded a $959,561.84 definitive, firm-fixed-price contract to Caredx, Inc., a for-profit medical testing company headquartered in Brisbane, California. The contract is for the provision of AlloMap and AlloSure post-heart transplant rejection surveillance tests to veterans in the Palo Alto, California area over a five-year period, with a base year and four one-year option periods.

This contract award is related to a larger Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle managed by the VA's Veterans Integrated Service Network 21 (VISN 21). Caredx has secured multiple federal contracts with the VA and other agencies to provide specialized genetic and molecular testing solutions focused on organ transplant diagnostics. The contract has no set-aside designation.

Generated 2/21/25, 9:47 AM